<?xml version="1.0" encoding="UTF-8"?><informationTable xmlns="http://www.sec.gov/edgar/document/thirteenf/informationtable" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><infoTable><nameOfIssuer>BIOHAVEN LTD</nameOfIssuer><titleOfClass>COM</titleOfClass><cusip>G1110E107</cusip><value>39202368</value><shrsOrPrnAmt><sshPrnamt>2936507</sshPrnamt><sshPrnamtType>SH</sshPrnamtType></shrsOrPrnAmt><investmentDiscretion>DFND</investmentDiscretion><otherManager>1, 2</otherManager><votingAuthority><Sole>2936507</Sole><Shared>0</Shared><None>0</None></votingAuthority></infoTable><infoTable><nameOfIssuer>CYTOKINETICS, INC</nameOfIssuer><titleOfClass>COM</titleOfClass><cusip>23282W605</cusip><value>64617637</value><shrsOrPrnAmt><sshPrnamt>980392</sshPrnamt><sshPrnamtType>SH</sshPrnamtType></shrsOrPrnAmt><investmentDiscretion>DFND</investmentDiscretion><otherManager>1, 2</otherManager><votingAuthority><Sole>980392</Sole><Shared>0</Shared><None>0</None></votingAuthority></infoTable><infoTable><nameOfIssuer>ZENAS BIOPHARMA, INC.</nameOfIssuer><titleOfClass>COM</titleOfClass><cusip>98937L105</cusip><value>64408406</value><shrsOrPrnAmt><sshPrnamt>2388150</sshPrnamt><sshPrnamtType>SH</sshPrnamtType></shrsOrPrnAmt><investmentDiscretion>DFND</investmentDiscretion><otherManager>1, 2</otherManager><votingAuthority><Sole>2388150</Sole><Shared>0</Shared><None>0</None></votingAuthority></infoTable><infoTable><nameOfIssuer>KAILERA THERAPEUTICS</nameOfIssuer><titleOfClass>COM</titleOfClass><cusip>482931102</cusip><value>28040177</value><shrsOrPrnAmt><sshPrnamt>2455357</sshPrnamt><sshPrnamtType>SH</sshPrnamtType></shrsOrPrnAmt><investmentDiscretion>DFND</investmentDiscretion><otherManager>1, 2</otherManager><votingAuthority><Sole>2455357</Sole><Shared>0</Shared><None>0</None></votingAuthority></infoTable></informationTable><!-- Other Managers: 1|Royalty Pharma Manager, LLC||0002077508||^2|Royalty Pharma plc||0001802768|| --><!-- tableEntryCount=4 tableValueTotal=196268588 -->
